Trial Profile

A Prospective, Open label, Single-arm Clinical Trail to Evaluate the Safety and Efficacy of Apatinib MesylateTablets in Advanced Epithelial Ovarian Cancer failing to respond to Second-line Chemotherapy

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 04 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Nov 2016 Planned patient number changed from 20 to 40 since Chinese CTR is the only source.
27 Apr 2016 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com